Vimarsana
Biggest News Aggregation in the World

Page 5 - Ben Brahim News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ben Brahim. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ben Brahim Today - Breaking & Trending Today

Transgene's Combined General Meeting of May 25, 2022 Seite 1 - Vimarsana News

Transgene's Combined General Meeting of May 25, 2022 Seite 1

25.05.2022 - Regulatory News: The Combined Ordinary and Extraordinary General Meeting of Transgene’s (Paris:TNG) shareholders was held today (May 25, 2022) at 10:00 a.m. at the Company’s headquarters (400 boulevard Gonthier d’Andernach – Parc d’Innovation – ... Seite 1

All of Transgene's preclinical and clinical assets progressed in line with expectations in Q1 2022 - Vimarsana News

All of Transgene's preclinical and clinical assets progressed in line with expectations in Q1 2022

Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, today announces its business update for the quarter ended March 31, 2022. Over the first quarter of 2022, all of Transgene’s preclinical and clinical assets progressed in line with ...

Are business trips a thing of the past? | DW Travel | DW - Vimarsana News

Are business trips a thing of the past? | DW Travel | DW

The coronavirus pandemic forced many companies to halt business travel almost overnight. The economic consequences for airlines and hotels have been dramatic, leaving many wondering if corporate travel can bounce back.

Source: dw.com
Transgene's Board of Directors Strengthens Its Governance and Proposes the Appointment of Dr. Alessandro Riva as Independent Chairman - Vimarsana News

Transgene's Board of Directors Strengthens Its Governance and Proposes the Appointment of Dr. Alessandro Riva as Independent Chairman

The roles of Chairman and Chief Executive Officer will be separated. Dr. Riva proposed as new independent Director and non-executive Chairman of the Board. With more than 30 years of experience

Transgene Confirms the Potential of Its Two Innovative Platforms and Expects Significant Clinical Results in 2022 - Vimarsana News

Transgene Confirms the Potential of Its Two Innovative Platforms and Expects Significant Clinical Results in 2022

TG4050 (myvac: First positive results from the two Phase I trials. Additional data to be presented at AACR 2022 in April. TG4001: First patient enrolled in Phase II study in June 2021. Active patient